Shriram Finance secures USD 468 million multi-currency social loan from BNP Paribas, DBS Bank, HSBC, and Sumitomo Mitsui Banking Corporation to expand financial services for small businesses and...

SEBI slapped penalties totaling Rs 11.90 crore on 19 entities for engaging in a 'pump and dump' scheme of Superior Finlease Ltd. shares. The regulator also barred them from the securities market...

Shriram Finance has agreed to sell its housing finance subsidiary, Shriram Housing Finance Limited (SHFL), to Warburg Pincus for Rs 4,630 crore. The deal is expected to be completed in February 2025.

Sanlam Ltd plans to increase its stake in Shriram General Insurance and Shriram Life Insurance to over 50% each, boosting its presence in the Indian market.

Sundaram Finance's net profit for H1 FY'24 surged 22% to Rs 648 crore, driven by record disbursements. Assets under management also grew significantly.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

BHIVE Workspace leases 42,000 sq ft office space in Bengaluru from Brigade Group, expanding its presence in the city's key business hubs. The new facility will support 1200+ seats, reflecting the...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.